These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12153695)

  • 1. Colocalization of CA19-9 and KL-6 to epithelial cells in dilated bronchioles in a patient with idiopathic pulmonary fibrosis complicated by diffuse alveolar damage.
    Shimizu Y; Hamada T; Tanaka Y; Sasaki A; Nemoto T
    Respirology; 2002 Sep; 7(3):281-4. PubMed ID: 12153695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CA19-9-producing idiopathic pulmonary fibrosis with diffuse alveolar damage and a high titer of KL-6--an autopsy case].
    Shimizu Y; Tanaka Y; Sasaki A; Nemoto T
    Nihon Kokyuki Gakkai Zasshi; 2001 May; 39(5):351-6. PubMed ID: 11510099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia.
    Yokoyama A; Kohno N; Kondo K; Ueda S; Hirasawa Y; Watanabe K; Takada Y; Hiwada K
    Respirology; 1998 Sep; 3(3):199-202. PubMed ID: 9767620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome.
    Ishizaka A; Matsuda T; Albertine KH; Koh H; Tasaka S; Hasegawa N; Kohno N; Kotani T; Morisaki H; Takeda J; Nakamura M; Fang X; Martin TR; Matthay MA; Hashimoto S
    Am J Physiol Lung Cell Mol Physiol; 2004 Jun; 286(6):L1088-94. PubMed ID: 12959931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.
    Kohno N; Awaya Y; Oyama T; Yamakido M; Akiyama M; Inoue Y; Yokoyama A; Hamada H; Fujioka S; Hiwada K
    Am Rev Respir Dis; 1993 Sep; 148(3):637-42. PubMed ID: 8368634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characterization of CA19-9 in patients with interstitial pneumonia showing pathological nonspecific interstitial pneumonia pattern].
    Totani Y; Saito Y; Miyachi H; Yoneda Y; Shimizu H; Hoshino T; Hayashi M; Uchiyama Y; Isogai S; Matsui K; Hashimoto Y; Umemoto M; Sasaki F; Okazawa M; Sakakibara H
    Nihon Kokyuki Gakkai Zasshi; 2005 Feb; 43(2):77-83. PubMed ID: 15770937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked elevation of CA19-9 in a patient with idiopathic pulmonary fibrosis: CA19-9 as a bad prognostic factor.
    Fujita J; Obayashi Y; Yamadori I; Ohtsuki Y; Miyawaki H; Hojo S; Furukawa Y; Takahara J
    Respirology; 1998 Sep; 3(3):211-4. PubMed ID: 9767623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical study of KL-6 in pulmonary tuberculosis].
    Inoue T; Ishida A; Yamamoto T; Seki R; Maruyama H; Noda T; Yashiro T; Tadokoro M
    Nihon Kokyuki Gakkai Zasshi; 2001 Aug; 39(8):553-8. PubMed ID: 11681019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.
    Takahashi T; Munakata M; Suzuki I; Kawakami Y
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1294-8. PubMed ID: 9769294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of serum KL-6 antigen in a patient with radiation pneumonia.
    Hamada H; Kohno N; Akiyama M; Hiwada K
    Chest; 1992 Mar; 101(3):858-60. PubMed ID: 1541162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanism of lung tissue remodeling in the progression of idiopathic pulmonary fibrosis].
    Kogan EA; Tyong FV; Demura SA
    Arkh Patol; 2010; 72(4):30-6. PubMed ID: 21086635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis.
    Bandoh S; Fujita J; Ohtsuki Y; Ueda Y; Hojo S; Tokuda M; Dobashi H; Kurata N; Yoshinouchi T; Kohno N; Takahara J
    Ann Rheum Dis; 2000 Apr; 59(4):257-62. PubMed ID: 10733471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-1, B7-2 and class II MHC molecules in idiopathic pulmonary fibrosis and bronchiolitis obliterans-organizing pneumonia.
    Kaneko Y; Kuwano K; Kunitake R; Kawasaki M; Hagimoto N; Hara N
    Eur Respir J; 2000 Jan; 15(1):49-55. PubMed ID: 10678620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis.
    Sato S; Nagaoka T; Hasegawa M; Nishijima C; Takehara K
    Dermatology; 2000; 200(3):196-201. PubMed ID: 10828626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis.
    Inoue Y; Nishimura K; Shiode M; Akutsu H; Hamada H; Fujioka S; Fujino S; Yokoyama A; Kohno N; Hiwada K
    Tuber Lung Dis; 1995 Jun; 76(3):230-3. PubMed ID: 7548906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung injury and serum markers].
    Suwabe A
    Rinsho Byori; 2002 Nov; 50(11):1061-6. PubMed ID: 12491603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6.
    Kohno N; Kyoizumi S; Awaya Y; Fukuhara H; Yamakido M; Akiyama M
    Chest; 1989 Jul; 96(1):68-73. PubMed ID: 2661160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of myelodysplastic syndrome complicated by pulmonary alveolar proteinosis with a high serum KL-6 level.
    Kajiume T; Yoshimi S; Nagita A; Kobayashi K; Kataoka N; Nakajima M; Matsushima T
    Pediatr Hematol Oncol; 1999; 16(4):367-71. PubMed ID: 10407875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis.
    Nakajima M; Manabe T; Niki Y; Matsushima T
    Thorax; 1998 Sep; 53(9):809-11. PubMed ID: 10319067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibody against granulocyte/macrophage colony-stimulating factor and KL-6 in idiopathic pulmonary alveolar proteinosis.
    Nara M; Sano K; Ogawa H; Tamada T; Nagaoka M; Okada K; Watanabe M; Moriya T; Miki H; Nakata K; Ichinose M; Hattori T
    Tohoku J Exp Med; 2006 Apr; 208(4):349-54. PubMed ID: 16565598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.